COMMUNIQUÉS West-GlobeNewswire

Interim Report Q1 2025: Growth challenged by market uncertainty – proactive cost mitigation initiated to support long-term margins
30/04/2025
Highlights The Hearing division delivered -1% organic revenue growth driven by a strong initial uptake of ReSound Vivia, but off-set by a challenged U.S. market as well as some slowdown of existing products in [...]
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
30/04/2025
Information relating to the holding of the Combined Shareholders’ Meeting of 21 May 2025 of Ipsen S.A. Formalities for making available and consulting preparatory documents to the Meeting PARIS, FRANCE, 30 April 2025 - [...]
EssilorLuxottica: EssilorLuxottica 2025 Annual Shareholders’ Meeting
30/04/2025
EssilorLuxottica 2025 Annual Shareholders’ Meeting All resolutions proposed by the Board of Directors adopted Dividend of Euro 3.95 per share, with option for payment in shares Paris, France (30 April 2025 – 6:00 pm [...]
EssilorLuxottica: Assemblée générale 2025 d’EssilorLuxottica
30/04/2025
Assemblée générale 2025 d’EssilorLuxottica Toutes les résolutions proposées par le Conseil d’administration adoptées Dividende de 3,95 € par action, avec possibilité de choisir un versement en actions Paris, France (30 [...]
IPSEN S.A - Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée Générale 2025
30/04/2025
Information réglementée Destiné uniquement aux médias internationaux et à la communauté d’investisseurs Informations concernant la tenue de l’Assemblée Générale Mixte du 21 mai 2025 d’Ipsen S.A. Modalités de mise à [...]
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024
30/04/2025
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024 NANTES, France, 30 avril 2025, 18 heures - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), une société de [...]
Best Probiotics for Bloating and Gas 2025: Top Probiotic Gut Health Supplements from YourBiology
30/04/2025
GLASGOW, United Kingdom, April 30, 2025 (GLOBE NEWSWIRE) -- YourBiology Gut+ is the best probiotic for bloating, gas, and constipation—powered by Lactobacillus, Bifidobacterium, prebiotics, enzymes, and Vitamin D3 to [...]
Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director
30/04/2025
Leiden, the Netherlands, April 30, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that the Company’s 2025 Annual General Meeting of Shareholders (the “AGM”) [...]
Mise à disposition du rapport financier annuel 2024
30/04/2025
Communiqué de presse Mise à disposition du rapport financier annuel 2024 Dijon, France le 30 avril 2025 (17h45 CET) -- CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique spécialisée en phase [...]
Mise à disposition du rapport financier annuel 2024
30/04/2025
Communiqué de presse Mise à disposition du rapport financier annuel 2024 Dijon, France le 30 avril 2025 (17h45 CET) -- CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique spécialisée en phase [...]
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions
30/04/2025
EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies to restore [...]
Guidance updated: Impact from and mitigation to navigate the global trade environment
30/04/2025
Following the recent announcements by the U.S. administration regarding tariffs, GN now takes further actions to counter the negative direct and indirect effects from the increased tariff levels. With the actions, GN is [...]
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
30/04/2025
KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) , a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today announced that it [...]
NeuroSigma Announces New Clinical Trial of Monarch eTNS System for Treatment of ADHD in Children with Fetal Alcohol Syndrome at UCLA
30/04/2025
Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) First phase of trial will enroll up to 30 children ages 8 – 12 with exposure to alcohol during [...]
Arialief Reviews (DOCTOR INVESTIGATION REVEALS) Natural, Science-Backed Relief for Chronic Pain & Inflammation
30/04/2025
Arialief offers innovative solutions for chronic pain and inflammation. Discover natural, non-addictive relief with our science-backed products. Improve your wellness journey today! FINDLAY, Ohio, April 30, 2025 (GLOBE [...]
X-Chem Expands Strategic Collaboration With Orion Pharma to Accelerate Orion’s Early Drug Discovery From Hit to Candidate
30/04/2025
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in DNA-encoded library (DEL) technology and data-driven drug discovery, has announced an expanded collaboration with Orion Pharma. The agreement [...]
BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
30/04/2025
MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton & Co. Healthcare Investor [...]
Corporate Update
30/04/2025
Boston, MA, April 30, 2025 (GLOBE NEWSWIRE) -- Vystar ® Corporation (OTCQB: VYST) Vystar received notice of final approval of its Form 15C-211 application. In addition, today the Company moved from the Pink Sheets to [...]
HLTH 2025 Launches Groundbreaking New Experiences in AI, Pharma, and Diagnostics – While Returning Classics Get a Fresh Twist
30/04/2025
LAS VEGAS, April 30, 2025 (GLOBE NEWSWIRE) -- HLTH Inc., the catalyst for global healthcare innovation, returns to Las Vegas on October 19–22, 2025, with a bold new agenda designed to redefine the future of healthcare. [...]

Pages